Goldman Sachs Group Inc Cure Vac N.V. Put Options Transaction History

Goldman Sachs Group Inc

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 May 14, 2024	BUY	$13.18 - $19.41 $263,600 - $388,200	20,000 New	20,000 $272,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $1.05 Million - $1.55 Million	-80,000 Reduced 80.0%	20,000 $272,000
Q3 2021 Nov 10, 2021	BUY	$49.26 - $74.5 $4.93 Million - $7.45 Million	100,000 New	100,000 $5.46 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.